Literature DB >> 9342251

Activation of latent HIV-1 by Mycobacterium tuberculosis and its purified protein derivative in alveolar macrophages from HIV-infected individuals in vitro.

Z Toossi1, K Nicolacakis, L Xia, N A Ferrari, E A Rich.   

Abstract

Although Mycobacterium tuberculosis (MTB) and its purified protein derivative (PPD) induce HIV in cell lines that harbor latent HIV infection, it is not known whether similar activation of HIV in primary macrophages infected with HIV occurs. This possibility was examined using alveolar macrophages (AM) obtained by bronchoalveolar lavage of HIV-infected subjects with CD4 counts <200/microl. PPD induced transcription of HIV in AM from HIV-infected subjects by reverse transcription-polymerase chain reaction (RT-PCR). PPD and MTB infection also induced HIV production in AM from these HIV-infected patients, determined by HIV p24 enzyme-linked immunosorbent assay (ELISA). Viral production in AM required short periods of cell contact with allogeneic lymphocytes. HIV was only inducible, however, in AM from subjects with detectable HIV load (one to three copies of HIV DNA/1000 cells). Thus, MTB and its PPD can induce HIV in latently infected AM.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9342251     DOI: 10.1097/00042560-199708150-00001

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  17 in total

Review 1.  Tuberculosis and HIV Coinfection.

Authors:  Judith Bruchfeld; Margarida Correia-Neves; Gunilla Källenius
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-26       Impact factor: 6.915

2.  Human immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytes.

Authors:  H Ruppach; P Nara; I Raudonat; Z Elanjikal; H Rübsamen-Waigmann; U Dietrich
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients.

Authors:  Z Toossi; H Mayanja-Kizza; C S Hirsch; K L Edmonds; T Spahlinger; D L Hom; H Aung; P Mugyenyi; J J Ellner; C W Whalen
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

4.  Transcriptional activation of HIV by Mycobacterium tuberculosis in human monocytes.

Authors:  Z Toossi; L Xia; M Wu; A Salvekar
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

5.  Interferon-gamma and tumour necrosis factor-alpha production by CD4+ T and CD8+ T lymphocytes in AIDS patients with tuberculosis.

Authors:  R M de Castro Cunha; E G Kallas; D S Rodrigues; M Nascimento Burattini; R Salomao
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

6.  Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.

Authors:  C C Whalen; P Nsubuga; A Okwera; J L Johnson; D L Hom; N L Michael; R D Mugerwa; J J Ellner
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

Review 7.  Tuberculosis and HIV disease: two decades of a dual epidemic.

Authors:  Muktar H Aliyu; Hamisu M Salihu
Journal:  Wien Klin Wochenschr       Date:  2003-10-31       Impact factor: 1.704

Review 8.  Host hindrance to HIV-1 replication in monocytes and macrophages.

Authors:  Anna Bergamaschi; Gianfranco Pancino
Journal:  Retrovirology       Date:  2010-04-07       Impact factor: 4.602

9.  Recombinant gamma interferon stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients.

Authors:  Rany Condos; Bindu Raju; Antony Canova; Ben-Yang Zhao; Michael Weiden; William N Rom; Richard Pine
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 10.  Chronic Immune Activation in TB/HIV Co-infection.

Authors:  Riti Sharan; Allison N Bucşan; Shashank Ganatra; Mirko Paiardini; Mahesh Mohan; Smriti Mehra; Shabaana A Khader; Deepak Kaushal
Journal:  Trends Microbiol       Date:  2020-04-22       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.